|
Leronlimab
|
NCIT_C137824 |
[A humanized immunoglobulin (Ig) G4 monoclonal antibody against CC chemokine receptor 5 (CCR5; CD195), with potential activity as a human immunodeficiency virus (HIV) entry blocker and potential protective activity against graft-versus-host disease (GvHD). Upon administration, leronlimab targets and binds to CCR5 expressed on T-cells. This blocks HIV cell entry, which prevents HIV infection and/or reduces HIV viral load. In addition, blocking CCR5 by PRO 140 decreases CCR5-mediated signaling and the CCR5-induced migration of donor cells into tissues after an allogeneic hematopoietic cell transplantation (HCT). Blocking CCR5 may therefore prevent or reduce GvHD. CCR5, a co-receptor needed for HIV cell entry, plays a key role in immunomodulation. Expressed on monocytes, activated T-cells and dendritic cells (DCs), CCR5 can regulate chemotaxis. Lymphocyte trafficking via chemokine receptors, such as CCR5, and recruitment to target organs, plays a critical role in alloreactive responses.] |
|
drug
|
CHEBI_23888 |
[Any substance which when absorbed into a living organism may modify one or more of its functions. The term is generally accepted for a substance taken for a therapeutic purpose, but is also commonly used for abused substances.] |
|
acquired metabolic disease
|
DOID_0060158 |
[A disease of metabolism that has _material_basis_in enzyme deficiency or accumulation of enzymes or toxins which interfere with normal function due to an endocrine organ disease, organ malfunction, inadequate intake, dietary deficiency, or malabsorption.] |
|
disease of metabolism
|
DOID_0014667 |
[A disease that involving errors in metabolic processes of building or degradation of molecules.] |
|
axon guidance
|
GO_0007411 |
[The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.] |
|
neuron projection guidance
|
GO_0097485 |
[The process in which the migration of a neuron projection is directed to a specific target site in response to a combination of attractive and repulsive cues.] |
|
positive regulation by virus of host cytokine production
|
GO_0044832 |
[The process in which a virus increases the frequency, rate or extent of cytokine production in its host organism.] |
|
modulation by virus of host cytokine production
|
GO_0044831 |
[Any process in which a virus modulates the frequency, rate or extent of cytokine production in its host organism.] |
|
nuclear matrix
|
GO_0016363 |
[The dense fibrillar network lying on the inner side of the nuclear membrane.] |
|
cellular_component
|
GO_0005575 |
[A location, relative to cellular compartments and structures, occupied by a macromolecular machine when it carries out a molecular function. There are two ways in which the gene ontology describes locations of gene products: (1) relative to cellular structures (e.g., cytoplasmic side of plasma membrane) or compartments (e.g., mitochondrion), and (2) the stable macromolecular complexes of which they are parts (e.g., the ribosome).] |
|
kidney epithelium development
|
GO_0072073 |
[The process whose specific outcome is the progression of an epithelium in the kidney over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.] |
|
bodily process
|
OGMS_0000060 |
[A process in which at least one bodily component of an organsim participates.] |
|
cell cycle G2/M phase transition
|
GO_0044839 |
[The cell cycle process by which a cell in G2 phase commits to M phase.] |
|
cellular process
|
GO_0009987 |
[Any process that is carried out at the cellular level, but not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.] |
|
disinfectant
|
CHEBI_48219 |
[An antimicrobial agent that is applied to non-living objects to destroy harmful microorganisms or to inhibit their activity.] |
|
chemical entity
|
CHEBI_24431 |
[A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.] |
|
Baloxavir marboxil
|
DRON_00837844 |
[An orally bioavailable prodrug and influenza cap-dependent endonuclease (CEN) inhibitor, with antiviral activity. Upon administration of baloxavir marboxil, the agent is converted by hydrolysis to its active metabolite baloxavir. Baloxavir targets, binds to and inhibits the CEN activity of the influenza polymerase acidic (PA) protein, an influenza virus-specific enzyme in the viral RNA polymerase complex required for the initiation of influenza gene transcription.] |
|
cardiovascular measurement
|
CMO_0000001 |
|
|
clinical measurement
|
CMO_0000000 |
|
|
measurement datum
|
IAO_0000109 |
[A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.] |